ResMed Europe - Middle East COVID-19 supply continuity

Looking for ResMed information on COVID-19 ? See below for regular and up-to-date communication, or contact our customer service team if you have questions.

At ResMed, we are dedicated to providing respiratory care products to countries and healthcare systems across the globe, just as we have done for decades. Now, as coronavirus (COVID-19) continues to spread throughout the world, we stand strong alongside healthcare providers and professionals treating those in need of a very high level of care.

Our long-time commitment to improving the lives of people with breathing disorders serves patients especially well in these challenging times. We are making all efforts to reach out to our community of customers to inform, engage and educate on how essential treatment can be delivered as soon as possible. Our range of invasive and non-invasive ventilation systems, CPAP therapy, oxygen therapy, masks and monitoring software solutions continue to help administer vital respiratory support in hospitals and homes.

Responses to customer questions about coronavirus

Supply chain & ordering

The rapidly evolving global situation caused by the Coronavirus disease (COVID-19) is causing much concern within the medical device community, and indeed within our own customer base. Our primary focus is to ensure continuity of care and the continued supply of products to meet the needs of patients while protecting our staff and the wider community.

ResMed as a global company is in constant dialogue with governments and health care systems around the world to understand needs and work collaboratively to respond to this crisis. We have implemented measures to increase capacity through improved access to component suppliers and transport lines in order to maximise production and delivery of products.

As a manufacturer of respiratory devices and equipment, and more broadly as a community of care providers to patients in need of these life changing and sometimes life saving devices, it is up to all of us to put in place processes and policies that maximise the availability of this equipment for patients who need it, as soon as they need it, wherever they reside and whoever is in charge of their care.

In an attempt to play our part to ensure the adequate supply of our products to patients across Europe – Middle East, until further notice we will be monitoring all orders being placed on us and reserve the right to phase the shipment of requested quantities in an attempt to maintain continuity of care across the region.

Should you have any questions or special requests please contact your ResMed representative.

We are working to review and prioritise orders. As such, we must consider the use of partial and/or progressive delivers of your orders to ensure continuity of supply for as many customers as possible. Our main objective is to guarantee maximum continuity of care at the national and global level.

In order to facilitate the best possible supply of our products, having an early indication of larger volumes needed for the next few weeks will be essential in managing our manufacturing capacities. Our objective is to maintain continuity of care across countries, so we will be monitoring and prioritizing all orders being placed. To this end, we may part fulfil orders of requested quantities where necessary.

In this case we ask you to approach your ResMed representative in order for them to centralize your different needs.

All ventilator orders are currently being monitored in order for us to allocate them across the European and the Middle East regions. Consequently, we have implemented a biweekly allocation process. Your order could be split into several deliveries which could phased over a period of time. In order to have a fair allocation process delivery volumes are being allocated very late in the process, and will be shipped for the next coming days.

To ensure an efficient process, unfortunately we are not able to give any advance delivery notification. However, all orders are kept in our system and fulfilled as soon as we have available stock. We are doing everything we can to ship as many orders as possible each day.

For customers that currently receive order acknowledgements:

All ventilator and range of accessories orders are currently being monitored to allow us to allocate them across the European and the Middle East regions. To maintain this, all ventilators are shown as backorders on your order acknowledgment. So as to have a fair allocation system, delivery volumes are being allocated very late in the process, to be shipped for the next coming days.

To ensure an efficient process, we are not able to send any advance delivery notification. However, if you have received a partial delivery and would like to confirm the number of outstanding items in an orderplease contact our customer service team. All outstanding orders or part-orders are kept in our system and will be reviewed during the next biweekly allocation process.

For non-ventilator products, backorders are shown on the order acknowledgment as normal. ResMed is fulfilling all backorders as soon as stock becomes available and our warehouses are working very hard to fulfil orders daily. We are aware that for some countries there are transport delays due to congestions at borders; rest assured, we are working tirelessly to keep goods flowing.

All orders are kept in our system and dealt with as quickly as possible.

 

For customers that currently do not receive order acknowledgements:

All ventilator and range of accessories orders are currently being monitored to allow us to allocate them across the European and the Middle East regions. So as to have a fair allocation system, delivery volumes are being allocated very late in the process, to be shipped for the next coming days.

 

To ensure an efficient process, we are not able to send any backorder notifications or advance delivery notification. However, if you have received a partial delivery and would like to confirm the number of outstanding items in an orderplease contact our customer service team. All outstanding orders or part-orders are kept in our system and will be reviewed during next the biweekly allocation process.

For non-ventilator products, backorders are fulfilled as soon as we have available stock. Again, to ensure process efficiency, we are not able to give any backorder notifications or advance delivery notification.

ResMed is fulfilling all backorders as soon as stock becomes available. Our warehouses are working very hard to fulfil orders daily. We know that for some countries there are transport delays due to congestions at borders; rest assured, we are working tirelessly to keep goods flowing.

All orders are kept in our system and dealt with as quickly as possible.

All ResMed ventilators are manufactured and assembled in Sydney and Singapore, and are safe for use.

Yes, all Chinese-made components for ResMed products are safe for use, and all components received at a ResMed manufacturing facility go through rigorous safety, cleanliness, and quality checks before manufacturing – processes designed to safeguard against such health threats as COVID-19.

In an effort to maximise our supply capacities and minimise our lead times, we are currently reducing the complexity of our product offering. We strive to seek your agreement on changes to your orders, before they are processed. If you have further questions about your specific order, please contact your local ResMed customer service team.

In an effort to maximise our supply capacities and minimise our lead times, we are currently reducing the complexity of our product offering. We strive to seek your agreement on changes to your orders, before they are processed. If you have further questions about your specific order, please contact your local ResMed customer service team.

Oxygen

Astral and Stellar are able to entrain supplemental oxygen through the device via an oxygen port. These devices are designed to be compatible with supplemental oxygen up to a level of 30 L/min.

Lumis devices are compatible with supplemental oxygen of up to 4 L/min in iVAPS mode, or up to
15 L/min in all other modes.

At a fixed rate of supplemental oxygen flow, the inhaled oxygen concentration will vary depending on the ventilation mode and settings, patient breathing pattern, mask selection, and leak rate.

FiO2

Astral:

When an adult patient is using a non-vented circuit (double limb and single limb with valve, invasive and non invasive), almost 100% FiO2 can be achieved with an additional 30L/min of supplemental oxygen and more than 80% FiO2 can be achieved with an additional 15L/min of supplemental oxygen.

Stellar:

When adding 30L/min of supplemental oxygen, more than 90% FiO2 can be achieved if there is no leak, and almost 80% with a leak of 20L/min.

Astral and Stellar

 To add supplemental oxygen, please follow the instructions below:

  1. Unlock the low flow oxygen inlet at the rear of the device by pushing up on the locking clip.
  2. Insert one end of the oxygen supply tubing into the oxygen port connector. The tubing will automatically lock into place.
  3. Attach the other end of the oxygen supply tubing to the oxygen supply.
  4. Start ventilation.
  5. Turn on oxygen and adjust (at the oxygen supply) to the prescribed flow rate or FiO2 level.

For Astral devices:

For Stellar devices:

To remove supplemental oxygen:

 Before you remove supplemental oxygen from the device, ensure the oxygen supply has been turned off.

  1. Unlock the low flow oxygen inlet at the rear of the device by pushing up on the locking clip.
  2. Remove the oxygen port connector from the low flow oxygen inlet.

A low pressure oxygen connector (product code: 24971) is needed to connect the low flow oxygen inlet to the oxygen supply tubing. Please see below.

Lumis

To connect supplemental oxygen to Lumis devices, you can either use a ClimateLineAir Oxy tube or an oxygen connector port. For more information on how to set up the device with supplemental oxygen, refer to the user guide supplied with the accessory you choose to use.

Please note:

  • Adding oxygen may affect the delivered pressure and accuracy of the displayed and reported values (e.g. leak, minute ventilation and AHI).
  • Always make sure that the device is on, and airflow generated, before the oxygen supply is turned on. Always switch off the oxygen supply before turning off the device. Unused oxygen can accumulate within the device enclosure and presents a fire hazard.

Filters

For all devices (Astral, Stellar and Lumis), it is recommended that an antibacterial Heat Moisture Exchange Filter (HME) or antibacterial filter will be used to reduce the risk of contamination. While ResMed do supply these filters, other manufacturers can provide similar filters with the same antiviral/antibacterial properties.

To prevent the risk of cross-contamination, it is essential that an antibacterial filter is placed on the inspiratory port if the device is to be used on multiple patients .

Please note that the filters need to be changed frequently (for more precise information please refer to the filter user instruction) and also when the devices are used on multiple patients.

In addition, patients should follow ResMed’s user guide.

To avoid cross contamination, an antibacterial filter must be placed at the inspiratory port of Astral devices, or the air oultet of the Stellar and Lumis devices. The air tubing must be attached to the other side of the filter.

In Astral devices, antibacterial filters can be added to both the inspiratory port and the expiratory inlet. This is recommended when using nebulisers in order to protect the device.

Antibacterial HME Filter

The antibacterial HME filter must be placed between the patient end of the circuit and the patient interface.

Patient interfaces include any components placed after the single circuit’s expiratory valve or exhalation port, or a double limb circuit’s Y piece. Where there is a ResMed leak valve, connect the antibactierial HME filter to the patient side of this.

HMEs are passive humidification systems which retain heat and moisture from the patient’s exhaled gases via an internal membrane. An HME should not be used with active humidification.

In addition, patients should follow ResMed’s user guide

Astral: the machine filter filters particles of 10 micrometers and above. It is a dust filter and has to be changed between patients.

Stellar: The machine filter in the Stellar device has a bacterial filtration efficiency of 99.540% on area weight 100g/m². As viruses are typically smaller than bacteria (<0.1 micrometers), the filter is not guaranteed to remove them from the entrained air. The filter has to be changed between patients.

Lumis: The standard air filter in Lumis devices is made of non-woven polyester. The average efficiency is >75% for >7 micrometers dust. The hypoallergenic filter is made of acrylic and polypropylene fibres, in a polypropylene carrier. Its efficiency is >98% for >7-8 micrometers dust; >80% for >0.5 micrometers dust. Both types of filter have to be changed between patients.

Please note: If using an antibacterial filter, it must be checked for signs of moisture or other contaminants, particularly during humidification. Failure to do so could result in increased breathing system resistance.

Further instruction for using Stellar with an external humidifier:

Place the antibacterial filter at the air outlet, connect the external humidifier to the other side of the AB filter through the air tubing. Connect the other air tubing from the humidifier to the ResMed leak valve.

Do not use an antibacterial filter with the internal humidifier H4i.

In addition, patients should follow ResMed’s user guide.

HEPA filters remove at least 99.95% of particles with a diameter equal to 0.3 micrometers from the air which passes through.

Antibacterial and antibacterial HME filters filter particles >0.1 micrometers, meaning that they are more effecitive at filtering particles and microorganisms than HEPA filters.

In addition, patients should follow ResMed’s user guide and clinical guide.

To protect the Astral air inlet in a hospital setting, staff should ensure the air filter is not blocked by clothes or other objects, inspect the air inlet filter regularly and replace if necessary.

In addition, patients should follow ResMed’s user guide.

Disinfection

Information about cleaning and disinfecting the external device surfaces can be found in the clinical guide. However, as COVID-19 is a novel virus, specific decontamination methods have not yet been validated.

In addition, patients should follow ResMed’s cleaning procedures, as outlined in the user guide.

Information & communication

Detailed instructions are available on the product pages, and support pages, of our corporate website. You will find a range of official guides for ResMed products, including Set-Up  for our ventilation machines. Clinical guides will be on demand.

For further information, try our free education platform, ResMed Academy Online. Here, you can access a rich bank of educational resources, learning activities and expertise, designed to help improve patient outcomes.

If you do not already have an account, you can sign-up to ResMed Academy Online at no cost; the registration process is simple and should take no longer than a couple of minutes.

ResMed will soon be publishing more educational resources on the webinar.resmed.eu site, so please check back for further information soon.

For any further questions, please contact your local customer or sales representative.

We recognise that many of you have concerns regarding orders, supply and shipment in light of the coronavirus pandemic, and we are committed to providing regularly updated information to our customers across the globe. To help ensure our communications reach the community as soon as possible, we have created a dedicated COVID-19 FAQ page, which will be updated as and when new information becomes available to us.

For any further questions, please contact your local customer or sales representative.

How to prepare for COVID-19: useful guidelines from health organizations

As the coronavirus (COVID-19) outbreak unfolds across the globe, we endeavour to support patients, customers and healthcare professionals as they navigate this challenging time. ResMed is committed to providing all possible guidance and education for our global customer base.

To aid access to relevant and verifiable information about COVID-19, we are signposting to a range of official websites. These reliable sources publish data, research findings and public health advice regularly and, wherever possible, are country specific.

We appreciate that due to the swift progression of the virus, best-practice is changing rapidly. By providing these links, we hope to guide our customers to real-time updates to assist them in their response.

 

The World Health Organisation (WHO) educates and informs citizens worldwide on a range of health matters. During a health crisis, the WHO provides invaluable research and situation reports to track events as they evolve.

 

“WHO” current research

“WHO” situation reports

European health agencies differ in their advice surrounding containment, treatment and public health restrictions with regard to COVID-19. To help you find the most relevant information, please click on a country-specific link below to find out what your healthcare authority recommends.

 

  • Europe-wide

European Respiratory Society (ERS)

European Society of Intensive Care Medicine

European Society of Anaestesiology​ (ESA)

 

  • UNITED KINDGOM

British Thoracic Society​ (BTS)

The Faculty of Intensive Care Medicine (FICM) – for critical care guidance

 

For healthcare professionals, we are working diligently to source the most pertinent research on COVID-19. The list below will be updated to reflect emerging insights from the medical field, as part of our commitment to support those working on frontline or ongoing response efforts.

The Society of Critical Care Medicine (SCCM) is US-based body which provides resources and updates for those working in the critical care community during times of disaster and emergency.

https://www.sccm.org/disaster?utm_source=COVID19_SSC

To access guidance for clinicians from the SCCM:

“Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)” https://www.sccm.org/getattachment/Disaster/SSC-COVID19-Critical-Care-Guidelines.pdf?lang=en-US

For information from the SCCM on possible treatment pathways for Covid-19 patients with hypoxia:

https://www.sccm.org/getattachment/Disaster/SCCM-COVID-19-Infographics1.pdf?lang=en-US

For information from the SCCM on various treatment pathway guidelines for Covid-19 patients:

https://www.sccm.org/getattachment/Disaster/SCCM-COVID-19-Infographics2.pdf?lang=en-US